Literature DB >> 20737143

Long-term outcome in patients treated for benign dural arteriovenous fistulas of the posterior fossa.

Andrea Bink1, Joachim Berkefeld, Lubov Kraus, Christian Senft, Ulf Ziemann, Richard du Mesnil de Rochemont.   

Abstract

INTRODUCTION: Dural arteriovenous fistula (dAVF) draining into a dural sinus without recruitment of cortical veins is regarded as relatively benign lesion and treatment is advocated only if the patient is severely affected by the symptoms. The aim of this study was to compare the clinical outcomes in patients who received endovascular treatment or no treatment, respectively.
METHODS: Twenty-one patients presented consecutively with pulsating tinnitus as leading symptom and with angiographically proven dAVF at the transverse or sigmoid sinus (Borden I). Nine patients underwent different types of endovascular embolisation, and 12 patients were not treated. After a median follow-up period of 2.3 years, outcome was evaluated by assessing the patients' symptoms and scores on the mRS, EQ-5D, SF-36 and HIT-6 scales.
RESULTS: Complete long-term closure of the dAFV was achieved in two out of nine cases; subtotal occlusion was found in seven patients. Pulsating tinnitus persisted less frequently in treated than in untreated patients. Neurologic symptoms occurred in both groups. Neither these findings nor the clinical outcome and scores on the quality-of-life scales varied substantially between the two groups.
CONCLUSION: Partial treatment did not resolve the clinical symptoms of patients with "benign" dural AVF in the follow-up and was not clearly superior to conservative management. These results suggest that embolisation should be offered only if there is a possibility of a complete cure without major periinterventional risks. Further studies should be performed to assess the risk-benefit ratio of pursuing more aggressive treatment strategies in patients with unbearable symptoms.

Entities:  

Mesh:

Year:  2010        PMID: 20737143     DOI: 10.1007/s00234-010-0754-x

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  25 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project.

Authors:  J E Ware; B Gandek
Journal:  J Clin Epidemiol       Date:  1998-11       Impact factor: 6.437

3.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

4.  Benign cranial dural arteriovenous fistulas: outcome of conservative management based on the natural history of the lesion.

Authors:  Junichiro Satomi; J Marc C van Dijk; Karel G Terbrugge; Robert A Willinsky; M Christopher Wallace
Journal:  J Neurosurg       Date:  2002-10       Impact factor: 5.115

5.  The validity of classification for the clinical presentation of intracranial dural arteriovenous fistulas.

Authors:  M A Davies; K TerBrugge; R Willinsky; T Coyne; J Saleh; M C Wallace
Journal:  J Neurosurg       Date:  1996-11       Impact factor: 5.115

6.  Evolution of endovascular management of intracranial dural arteriovenous fistulas: single center experience.

Authors:  Rashmi Saraf; Manish Shrivastava; W Siddhartha; Uday Limaye
Journal:  Neurol India       Date:  2010 Jan-Feb       Impact factor: 2.117

7.  Endovascular treatment of intracranial dural arteriovenous fistulas with cortical venous drainage: new management using Onyx.

Authors:  C Cognard; A C Januel; N A Silva; P Tall
Journal:  AJNR Am J Neuroradiol       Date:  2007-11-07       Impact factor: 3.825

8.  Endovascular treatment of cranial dural arteriovenous fistulae: a single-centre, 14-year experience and the impact of Onyx on local practise.

Authors:  Jason Hector Michael Macdonald; John S Millar; C S Barker
Journal:  Neuroradiology       Date:  2009-11-04       Impact factor: 2.804

9.  Onyx embolization as a first line treatment for intracranial dural arteriovenous fistulas with cortical venous reflux.

Authors:  V Panagiotopoulos; W Möller-Hartmann; S Asgari; I E Sandalcioglu; M Forsting; I Wanke
Journal:  Rofo       Date:  2008-12-19

10.  Ear necrosis resulting from the endovascular onyx-18 embolization of a dural arteriovenous fistula fed by the posterior auricular artery.

Authors:  Brian T Jankowitz; Nirav Vora; Tudor Jovin; Michael Horowitz
Journal:  J Neuroimaging       Date:  2008-11-03       Impact factor: 2.486

View more
  3 in total

1.  Surgical treatment for ruptured dural arteriovenous fistula with large intracranial hematoma.

Authors:  Xianwang Ye; Haifeng Wang; Yi Huang; Shengjun Zhou; Xiang Gao
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Delayed dural arteriovenous fistula after microvascular decompression for hemifacial spasm.

Authors:  Sung Han Kim; Won Seok Chang; Hyun Ho Jung; Jin Woo Chang
Journal:  J Korean Neurosurg Soc       Date:  2014-08-31

3.  Patients with pulse-synchronous tinnitus should be suspected to have elevated cerebrospinal fluid pressure.

Authors:  Ping Guo; Wenfang Sun; Suming Shi; Wuqing Wang
Journal:  J Int Med Res       Date:  2019-07-05       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.